Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-26-011257
Filing Date
2026-03-18
Accepted
2026-03-18 16:35:22
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 6487
  Complete submission text file 0001493152-26-011257.txt   7997
Mailing Address C/O SQZ BIOTECHNOLOGIES COMPANY 200 ARSENAL YARDS BOULEVARD, SUITE 210 WATERTOWN MA 02472
Business Address
Sharei Armon (Reporting) CIK: 0001829463 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41115 | Film No.: 26769749

Mailing Address OLGETTINA, NO. 58 MILAN L6 20132
Business Address OLGETTINA, NO. 58 MILAN L6 20132 39-02-2643-6639
Genenta Science S.p.A. (Issuer) CIK: 0001838716 (see all company filings)

EIN.: 000000000 | State of Incorp.: L6
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)